Dr. Nissen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273Fax+1 216-445-6855
Summary
- Dr. Steven Nissen is a cardiologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from University of Michigan Medical School and has been in practice 39 years. He specializes in preventive cardiology and is experienced in general cardiology, lipid disorders, preventive cardiology, hypertension, and coronary artery disease. He has more than 500 publications and over 90,000 citations.
Education & Training
- University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 1981 - 1983
- University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
- OH State Medical License 1992 - 2026
- CA State Medical License 1980 - 1993
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Northern Ohio Live Castle Connolly, 2006-2009
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia Start of enrollment: 2014 Oct 30
- The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis Start of enrollment: 2017 Jan 01
- Supplements, Placebo, or Rosuvastatin Study Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.Milind Y Desai, Kathy Wolski, Anjali Owens, Jeffrey B Geske, Sara Saberi
Circulation. 2024-11-18 - Interplay of Age and Risk Factor Control Upon Coronary Atheroma Progression.Iryna Dykun, Julie Carlo, Steven E Nissen, Samir R Kapadia, Stephen J Nicholls
Heart, Lung & Circulation. 2024-11-01 - 2 citationsObicetrapib-the Rebirth of CETP Inhibitors?Bliss Chang, Luke J Laffin, Ashish Sarraju, Steven E Nissen
Current Atherosclerosis Reports. 2024-10-01
Journal Articles
- Coronary Revascularization StrategiesSteven E Nissen, Faisal G Bakaeen, JAMA
- Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseSteven E Nissen, Jeffrey S Riesmeyer, JAMA Cardiology
- Original Investigation Effect of Evolocumab on Coronary Plaque CompositionSteven E Nissen, Ransi Somaratne, Rishi Puri, Christie M Ballantyne, ScienceDirect
- Join now to see all
Authored Content
- Coronary Revascularization StrategiesJuly 2020
- Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
- Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
- Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
- ADCY9 Genetic Variants and Cardiovascular Outcomes with Evacetrapib in Patients with High-Risk Vascular DiseaseJuly 2018
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
- Join now to see all
Press Mentions
- Testosterone Supplements Garner Attention from Men, WomenDecember 21st, 2024
- Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360November 18th, 2024
- Cleveland Clinic-Led Trial Finds Novel Drug Can Reduce Lipoprotein(a), an Important Risk Factor of Heart Disease, by More Than 80%November 18th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: